Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
This trial is active, not recruiting.
|Condition||aortic aneurysm, abdominal|
|Treatments||computed tomography angiography, magnetic resonance angiography|
|Start date||January 2006|
|End date||January 2009|
|Trial size||30 participants|
|Trial identifier||NCT00281411, METC.2005.01.291E|
After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with CT angiography yearly after Endovascular Aneurysm Repair (EVAR).
The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients. The advantages of MRA with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
Male or female participants of any age.
Inclusion Criteria: - Patient is planned for endovascular abdominal aortic aneurysm repair Exclusion Criteria: - contraindication for MRI examination - claustrophobia - pacemaker - other non-MRI compatible implants
|Official title||Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment|
|Principal investigator||W. Mali, MD PhD|
|Description||The FEAT trial (Follow-up of Endovascular Aneurysm Treatment) is designed as a prospective, single-center, follow-up study. 100 Patients will be enrolled in this study. These patients will undergo additional MRA-examinations the day before EVAR, the day after EVAR, 6 months and 1 year after EVAR. These patients also participate in the conventional CTA follow-up scheme which comprises a pre- and post-operative CTA and a CTA yearly thereafter. Coagulation parameters in the blood will be measured before and 1 year after EVAR.|
Call for more information